Big Pharma, beware of your former (and possibly current) employees in China. Novartis ($NVS) is the latest drugmaker to be fingered for bribery by an anonymous whistleblower, just a few days after Sanofi ($SNY) got the same treatment. And Chinese officials say they're stepping up their pharma investigation even further. Report